Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Study Completion Date

January 31, 2006

Conditions
Lymphoma
Interventions
DRUG

leucovorin calcium

DRUG

methotrexate

DRUG

thiotepa

Trial Locations (9)

30322

Winship Cancer Institute of Emory University, Atlanta

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

48202

Josephine Ford Cancer Center at Henry Ford Hospital, Detroit

35294-3410

Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham

33612-9497

H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02114

Massachusetts General Hospital Cancer Center, Boston

27157-1096

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

New Approaches to Brain Tumor Therapy Consortium

OTHER

NCT00045539 - Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma | Biotech Hunter | Biotech Hunter